AC Immune SA Ret. on equity
What is the Ret. on equity of AC Immune SA?
The Ret. on equity of AC Immune SA is -34.94%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on NASDAQ compared to AC Immune SA
What does AC Immune SA do?
ac immune is a clinical-stage swiss-based biopharmaceutical company, listed on nasdaq, which aims to become a global leader in precision medicine for neurodegenerative diseases. the company designs, discovers and develops therapeutic as well as diagnostic products intended to prevent and modify diseases caused by misfolding proteins. ac immune’s two proprietary technology platforms create antibodies, small molecules and vaccines designed to address a broad spectrum of neurodegenerative indications, such as alzheimer’s disease (ad). the company’s pipeline features nine therapeutic and three diagnostic product candidates – with five product candidates currently in clinical trials. the most advanced of these is crenezumab, a humanized anti-amyloid-β monoclonal igg4 antibody that targets monomeric and aggregated forms of amyloid-β, with highest affinity for neurotoxic oligomers. crenezumab is currently in two phase 3 clinical studies for ad, under a global program conducted by the collabor
Companies with ret. on equity similar to AC Immune SA
- 4basebio UK Societas has Ret. on equity of -35.06%
- Beam Global has Ret. on equity of -35.04%
- 3P Learning has Ret. on equity of -35.04%
- Arrow Minerals has Ret. on equity of -35.02%
- GSI Technology Inc has Ret. on equity of -34.98%
- Aldoro Resources has Ret. on equity of -34.96%
- AC Immune SA has Ret. on equity of -34.94%
- Altura Mining has Ret. on equity of -34.93%
- Warrior Gold has Ret. on equity of -34.93%
- Homestay Care has Ret. on equity of -34.92%
- Zagg Inc has Ret. on equity of -34.92%
- Terrain Minerals has Ret. on equity of -34.91%
- Gladiator Resources has Ret. on equity of -34.89%